— Know what they know.
Not Investment Advice

BDSX NASDAQ

Biodesix, Inc.
1W: -9.2% 1M: -26.9% 3M: +1.1% YTD: +229.1% 1Y: +230.6% 3Y: -37.5% 5Y: -85.2%
$21.95
+0.69 (+3.25%)
After Hours: $22.17 (+0.22, +1.03%)
Weekly Expected Move ±9.5%
$17 $19 $21 $23 $25
NASDAQ · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 38 · $173.1M mcap · 5M float · 2.15% daily turnover · Short 34% of daily vol
Credit Risk of going bust: higher than 87% of companies Debt: 29.3% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the second-riskiest tenth, about 1 in 87 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.04 (down 95%), Biodesix, Inc. would be worth roughly what it owes.
Total debt $71.8M against a stock market value of $173.1M.
Distance to default 1.97 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $23.4M (short-term plus half of long-term), stock volatility 101.0%; Altman Z'' -16.88. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Supply Chain Overview

3 relationships
3
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2022-11-21
Earliest Filing
2024-04-09
Latest Filing
partner: 3

Counterparties (Filed by BDSX)

3 relationships

Companies named in BDSX's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
William Blair & Company, L.L.C. — partner Underwriter for the follow-on equity offering 2024-04-09 View
Canaccord Genuity LLC — partner Underwriter for the follow-on equity offering 2024-04-09 View
William Blair & Company, L.L.C. — partner Sole underwriter for the public offering of common stock. 2022-11-21 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-08-05 Earnings Release; Exhibits View
2026-05-20 Shareholder Vote; Exhibits View
2026-05-04 Earnings Release; Exhibits View
2026-02-26 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-01-12 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-11-03 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-01 Other Events View
2025-09-15 Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla View
2025-09-11 Other Events; Financial Statements and Exhibits View
2025-08-07 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-05-21 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
2025-05-13 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-04-17 Departure/Election of Directors; Appointment of Officers View
2025-03-28 Notice of Delisting or Transfer View
2025-03-03 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-01-10 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-11-01 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-08-15 Regulation FD Disclosure; Financial Statements and Exhibits View
2024-08-07 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2024-05-23 Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms